Using a difficult-to-treat resistance index to gauge imbalance between countries’ antibiotic resistance prevalence and access to antibiotics @chc_yek@SameerKadri12
https://t.co/V3YX9Tvw1y
🆕️🔥Retrospective cohort study with target trial emulation
Adult patients with invasive GAS infections treated with β-lactam, linezolid appeared non-inferior to clindamycin suggesting linezolid as an alternative for adjunctive antitoxin therapy #idxposts https://t.co/9P6OVso6ev
🆕️🔥Large retrospective cohort study @TheLancetInfDis@SameerKadri12
Carbapenem use in extended-spectrum cephalosporin-resistant Enterobacterales infections in US hospitals and influence of @IDSAInfo guidance #idxposts
https://t.co/RUgbBIu3qY
Former NFL tight end @RobGronkowski spoke to members of Congress about the importance of addressing #antimicrobial resistance during a day of advocacy on Capitol Hill.
Show your support for the #PASTEUR Act👇 https://t.co/rL4XbkD5vs
So proud of Robin Avery winning the AST mentoring award!! Such a wonderful member of our transplant ID community and the award is so well deserved!! (Ps former MGH ID fellow!!)
Incredibly proud of @sarahrenee314 discussing at @HIMSS how she leveraged @PINC_AI near-real-time pandemic data in our lab for urgent solutions. See podcast: https://t.co/bqGouP7kQx @NIHClinicalCntr @NIHCritCare #epitwitter#bigdata
The unstoppable @SameerKadri12 with yet another award added to his long list of accomplishments! I count myself lucky to work with him and other prominent faculty at @NIHCritCare
Our paper just out in Lancet ID. One in 5 bacteremic pts in US hospitals received inappropriate empiric abx, raising mortality even without sepsis or resistance. We sorely need effective, interpretable, widely implemented rapid diagnostics for stewardship
https://t.co/ZST9HGtIzW